Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

My Top 2 Stocks: Netflix, Inc. (NFLX) and Intuitive Surgical, Inc. (ISRG)

Page 1 of 2

I’m an unabashed growth investor. Not just any old growth, but the kind of earth-shaking hypergrowth that comes with disrupting traditional business ideas. If our Rule Breakers newsletter had a star constellation in the zodiac, I’d be born under it.

So I hope you’re not surprised to learn that 4 of my 15 stock positions come straight from David Gardner’s growth-focused newsletter. Two more live on David’s side of the scorecard in our Stock Advisor service.

Here’s how I ended up making longtime Stock Advisor pick Netflix, Inc. (NASDAQ:NFLX) my largest holding, and how Rule Breaker Intuitive Surgical, Inc. (NASDAQ:ISRG) became my second-fattest position.

Netflix, Inc. (NASDAQ:NFLX)Netflix: Through thick and thin
Video maven Netflix, Inc. (NASDAQ:NFLX) is not just my largest holding but also my oldest. I first got into the stock at $28 per share, way back in 2006. That was when Blockbuster made a serious attempt to kill its newfangled rival, only to fatally weaken its own financial health instead. I had just done several months of intensive research on the movie rental industry, and came away convinced that Netflix, Inc. (NASDAQ:NFLX) had that game in the bag. That’s when I bought my first Netflix, Inc. (NASDAQ:NFLX) shares.

The stock price has multiplied more than five-fold since then, which goes a long way toward explaining its large stature in my portfolio. But that’s not the whole story.

Many investors might have taken their profits and headed for the exits when Netflix, Inc. (NASDAQ:NFLX) traded at $300 per share. I didn’t because I saw even higher values in the years ahead. The all-digital strategy of global domination had barely started to play out in those heady days of early 2011.

Many more might have — and did — run away when Netflix changed its service prices, separated the digital church from its DVD state, and wanted to cram a totally separate DVD service named Qwikster down our throats. This trifecta of management errors played out in a matter of weeks, and the stock lost three-quarters of its value.

I thought about the mistakes and, yes, I briefly considered selling. But CEO Reed Hastings saw the error of his ways, reversed the unforgivable Qwikster mistake (which might have worked just fine in 2013, mind you!), and vowed to tread more carefully when making large changes to the core business plan.

Netflix is still way ahead of the admittedly growing pack of hungry rivals. Everyone wants to rule the just-blossoming era of digital video distribution. So far, only Netflix has found a business model that works, and the company has a lead time of several years as the others figure out its secret sauce for customer satisfaction.

So I stayed. Not only that, but I bought more shares at $83. Hastings has done nothing to lose my long-term trust since then, and I still see outsized value in the stock.

This growth story is just getting started. I’m letting this winner run for the long haul. Quite possibly decades.

Intuitive Surgical: Betting on better outcomes
Intuitive Surgical, Inc. (NASDAQ:ISRG) is a different story. Like Netflix, Inc. (NASDAQ:NFLX), it exploits a large, lucrative, and precisely defined market with nearly monopolistic powers. Unlike Netflix, everybody already knows that Intuitive holds a monolopy.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!